Bumetanide Injection
Product Images NDC 83301-0080

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bumetanide (NDC 83301-0080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mullan Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bumetanide 01)

FDA Label Image

Principal Display Panel (1 mg Vial Carton)

This is a description of Bumetanide Injection, USP with NDC 83301-0080-2. It is intended for intravenous or intramuscular use and each vial contains 1 mg/4 mL of solution. The medication includes ingredients like sodium chloride, ammonium chloride, edetate sodium, benzyl alcohol, and has specific storage instructions. The product is a single-dose vial.*

FDA Label Image

Principal Display Panel (4 mL Vial Label)

This is a description of Bumetanide Injection, USP in 10 x 10 mL Single Dose Vials for Intravenous or Intramuscular use. Each vial contains 0.25 g of the active ingredient, sodium enoride, ammonium acetate, buffers, sodium, and benzyt alcohol. The pH is adjusted, and it is not made with natural rubber latex. The product is manufactured by Mulan Pharmaceutical Inc. in the USA and QILU Pharmaceutical in China. The recommended storage temperature is between 20 to 25°C, with excursions permitted between 15 to 30°C.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.